CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1326
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer’s disease ; volume:17 ; number:1 ; day:28 ; month:6 ; year:2022 ; pages:1-21 ; date:12.2022
Molecular neurodegeneration ; 17, Heft 1 (28.6.2022), 1-21, 12.2022
- Urheber
-
Puntambekar, Shweta S.
Moutinho, Miguel
Lin, Peter Bor-Chian
Jadhav, Vaishnavi
Tumbleson-Brink, Danika
Balaji, Ananya
Benito, Martin Alvarado
Xu, Guixiang
Oblak, Adrian
Lasagna-Reeves, Cristian A.
Landreth, Gary E.
Lamb, Bruce T.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13024-022-00545-9
- URN
-
urn:nbn:de:101:1-2022082008262302176213
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Puntambekar, Shweta S.
- Moutinho, Miguel
- Lin, Peter Bor-Chian
- Jadhav, Vaishnavi
- Tumbleson-Brink, Danika
- Balaji, Ananya
- Benito, Martin Alvarado
- Xu, Guixiang
- Oblak, Adrian
- Lasagna-Reeves, Cristian A.
- Landreth, Gary E.
- Lamb, Bruce T.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
miR‐132 loss de‐represses ITPKB and aggravates amyloid and TAU pathology in Alzheimer's brain
Cerebral amyloid angiopathy aggravates perivascular clearance impairment in an Alzheimer’s disease mouse model
Ultrastructural evidence of microglial heterogeneity in Alzheimer’s disease amyloid pathology
Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease
ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer’s disease
Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
Dual-probe fluorescence spectroscopy for sensitive quantitation of Alzheimer’s amyloid pathology
Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease
Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease
Cerebrospinal Fluid Cortisol and Dehydroepiandrosterone Sulfate, Alzheimer’s Disease Pathology, and Cognitive Decline
Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer’s disease
Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
miR‐132 loss de‐represses ITPKB and aggravates amyloid and TAU pathology in Alzheimer's brain
Cerebral amyloid angiopathy aggravates perivascular clearance impairment in an Alzheimer’s disease mouse model
Ultrastructural evidence of microglial heterogeneity in Alzheimer’s disease amyloid pathology
Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease
ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer’s disease
Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
Dual-probe fluorescence spectroscopy for sensitive quantitation of Alzheimer’s amyloid pathology
Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease
Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease
Cerebrospinal Fluid Cortisol and Dehydroepiandrosterone Sulfate, Alzheimer’s Disease Pathology, and Cognitive Decline
Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer’s disease
Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
miR‐132 loss de‐represses ITPKB and aggravates amyloid and TAU pathology in Alzheimer's brain
Cerebral amyloid angiopathy aggravates perivascular clearance impairment in an Alzheimer’s disease mouse model
Ultrastructural evidence of microglial heterogeneity in Alzheimer’s disease amyloid pathology
Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease
ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer’s disease
Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
Dual-probe fluorescence spectroscopy for sensitive quantitation of Alzheimer’s amyloid pathology
Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease
Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease
Cerebrospinal Fluid Cortisol and Dehydroepiandrosterone Sulfate, Alzheimer’s Disease Pathology, and Cognitive Decline